Antibody-drug conjugates and their development remains a central theme in ongoing research within the realm of ovarian cancer ...

Zymeworks Inc., a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

Kevin Simpson of Capital Wealth Planning said Meta Platforms, Inc. META -2.04% Get Free Report is his top pick out of the Mag ...

Treatment with Rina-S showed antitumor activity in heavily pretreated patients with advanced ovarian cancer, according to the ...

Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by challenges in social interaction, ...

New phase 3 data provide reassurance on safety, tolerability, and overall benefit-risk of mirvetuximab soravtansine (Elahere) for patients with folate receptor alpha-positive (FRα+), ...

Managing hypertension (high blood pressure) before, during, and after surgery is important to ensuring the best outcomes. If your blood pressure is too high before surgery, the procedure may need to ...

You can get folic acid deficiency anemia a few different ways. Here are some examples: You don’t eat enough foods that contain folic acid. This is the case for most people. You might not be ...

Rina-S, to which this complaint relates, is a clinical-stage, FRα (folate receptor-alpha)-targeted, Topo1 ADC, in Phase 3 development for the treatment of ovarian cancer and other FRα-expressing solid ...

The AMPA group of brain receptors have mostly been assumed to be calcium impermeable and so were not thought to contribute to the calcium-dependent mechanisms underlying learning and memory.

in women with folate receptor alpha (FRα)-positive platinum-resistant ovarian cancer (PROC) compared to chemotherapy. The U.S. Food and Drug Administration granted full approval to Elahere in ...